10th International Global Virus Network (GVN) Meeting
Organized by the Global Virus Network (GVN), The Mérieux Foundation (MF) & University of Veterinary Medicine Hannover (TiHo)
Les Pensieres Center for Global Health, Veyrier-Du-Lac, France
November 28-30th, 2018
Scientific Organizing Committee
Members Institutions Global Virus Network Dr. Christian Bréchot
Fondation Mérieux and the Global Virus Netowork Dr. Juliet Bryant
Fondation Mérieux and Global Virus Netowork Dr. Hubert Endtz
Institute of Human Virology at the University of Maryland School of Dr. Robert C. Gallo Medicine and the Global Virus Network
Global Virus Network Dr. Natalia Mercer
University of Veterinary Medicine Hannover and the Global Dr. Ab Osterhaus Virus Network
Fondation Mérieux Dr. Valentina Picot
Meeting Coordinator: Cindy Grasso, Fondation Mérieux
Scientific Program
Wednesday, November 28th, 2018
13h00-13h30 Registration
Christian Bréchot, Global Virus Network, 13h30-14h00 Welcome addresses Alain Mérieux, Fondation Mérieux, Ab Osterhaus, University of Veterinary Medicine Hannover
Eradication of Viruses Session 1 Chair: (20 min presentation + 5 min discussion for each speaker)
14h00-14h25 Smallpox Mariano Esteban, CNB, Spain
14h25-14h50 Measles Diane Griffin, JHU, USA
14h50-15h15 Polio Viruses: what are the final stumble Michel Zaffran, WHO blocks?
Malik Peiris, University of Hong 15h15-15h40 SARS eradication Kong, Hong Kong
Joaquim Ségales, CRESA, 15h40-16h05 Role of animal reservoirs Spain
16h05-16h35 Coffee break
Programmatic issues relating to Rino Rappuoli, GSK, Italy 16h35-17h00 immunization John Mackenzie, Curtin delivery/access/coverage??] or health University, Australia economics?
17h00-17h25 CEPI: development of vaccines for Melanie Saville?TBC, CEPI emerging viruses
Retroviruses: emergence and intervention strategies Session 2 Chair: (20 min presentation + 5 min discussion for each speaker)
Sharon Lewin, Doherty 17h25-17h50 HIV: HIV prevalence and pathogenesis Institute, Australia Jean-Louis Excler, IVI, South 17h50-18h15 HIV vaccine development Korea Robert C. Gallo, IHV at UMD, 18h15-18h40 HTLV’s origins and evolution USA Joshua James Anzinger, The 18h40-19h05 HIV in the Caribbean University of the West Indies at Mona, West Indies 19h15 Dinner
Thursday, November 29th, 2018
Arboviruses: emergence and intervention strategies Session 3 Chair: (20 min presentation + 5 min discussion for each speaker)
Johan Neyts, University of 8h05-8h30 Antiviral strategies Leuven, belgium Yellow Fever (re-emergence/ vaccine manufacturing dose shortage/ studies of Maurício Lacerda Nogueira, 8h30-8h55 dose saving and new production FAMERP, Brazil methods) Pathogenesis and clinical disease for Marc Lecuit, Institut 8h55-9h20 CHIKV and ZIKV Pasteur, France
9h20-9h45 Dengue Vaccine Joachim Hombach, WHO
ZIKA and CHIKV: epidemiology and 9h45-10h10 Scott Weaver, UTMB, USA vector transmission 10h10-10h40 Coffee break
10h40-11h05 Japanese encephalitis virus Masayuki Saijo, NIID, Japan
Gerhard Dobler, TBEV: Eurasian spread and vaccine 11h05-11h30 Bundeswehr Munchen, development Germany Amadou Sall, Institut 11h30-11h55 RVF virus Pasteur, Senegal Diagnosis and emergence potential of Xavier de Lamballerie, Aix- 11h55-12h20 arboviruses Marseille University, France Aaron S. Mweene, 12h20-12h45 TBC University of Zambia, Zambia 12h45-14h45 Group Picture and Lunch
Filo- and other HF viruses: outbreaks & preparedness Session 4 Chair: (20 min presentation + 5 min discussion for each speaker)
Stephan Becker, University of 14h45-15h10 Ebola and Marburg viruses Marburg, Germany Noel Tordo, Institut Pasteur, 15h10-15h35 Hanta viruses France Erica Ollman Saphire, Scripps, 15h35-16h00 Ebola USA
16h00-16h25 Lassa Robert Garry, Tulane Univeristy, USA 16h25-16h55 Coffee break
Respiratory Viruses Session 5 Chair: (20 min presentation + 5 min discussion for each speaker)
Pathogenesis and impact of respiratory Peter Openshaw, Imerial 16h55-17h20 viruses College London, UK
Ab Osterhaus, Univeristy of New kids on the block: an update: Flu, 17h20-17h45 Veterinary Medicine Hannover, HMPV, SARS/MERS, rhino Germany
RSV - latest update on phase III trials of 17h45-18h10 Michelle Crank, NIH, USA pre-fusion F vaccines
Adolfo Garcia-Sastre, Icahn 18h10-18h35 Influenza universal vaccines School of Medicine at Mt. Sinai, USA Respiratory viruses in 18h35-19h00 Meagan Deming, IHV, USA immunocompromised hosts 19h00 Dinner
Friday, November 30th, 2018
Viruses affecting the CNS and PNS: challenges Session 6 Chair: (20 min presentation + 5 min discussion for each speaker)
Harry Dalton, University of 8h30-8h55 HEV amd neurological disease Execter, UK
8h55-9h20 Rabies virus TBC
Justin Chu, National 9h20-9h45 Enteroviruses EV69/71 University, Singapore Bernie Roizman, The 9h45-10h10 Herpes viruses University of Chicago, USA
10h10-10h35 Flaviviruses Jim Sejvar, CDC, USA
10h35-11h05 Coffee break
Viral threats in crisis settings Session 7 Chair: (20 min presentation + 5 min discussion for each speaker)
Battle against Respiratory Viruses 11h05-11h30 TBC, WHO (BRaVe) initiative Virus threats and vaccination programs 11h30-11h55 in refugee setting (measles, RSV, flu, Stephen Chacko, WHO hepatitis A, rota, STD’s) Hubert Endtz, Fondation 11h55-12h20 Respiratory diseases and refugees Mérieux
12h20-13h20 Global Health Roundtable
The GVN Robert C. Gallo Award for 13h20-13h30 Scientific Excellence and Leadership Ceremony
13h30 Closing remarks & end of the meeting